Market Place
Sourcing Support
Century Therapeutics Announces ASH 2024 Poster Presentations
05 Nov 2024 //
GLOBENEWSWIRE
Century Therapeutics Reports Q3 2024 Financial Results & Updates
05 Nov 2024 //
GLOBENEWSWIRE
Century to Present at Guggenheim Healthcare Innovation Conference
04 Nov 2024 //
GLOBENEWSWIRE
Century Therapeutics Appoints CFO And CSO
26 Sep 2024 //
GLOBENEWSWIRE
Century Therapeutics Reports Q2 2024 Results And Business Updates
08 Aug 2024 //
GLOBENEWSWIRE
Century`s Phase 1 ELiPSE-1 Interim Results At ASCO 2024
03 Jun 2024 //
GLOBENEWSWIRE
Century Therapeutics iPSC Platform, Program Data At ASGCT 2024
10 May 2024 //
GLOBENEWSWIRE
Century Therapeutics Q1 2024 Financials And Business Updates
09 May 2024 //
GLOBENEWSWIRE
Century to Present at Chardan Cell Therapy Manufacturing Summit
23 Apr 2024 //
GLOBENEWSWIRE
Century $60M Private Placement, Clade Acquisition
11 Apr 2024 //
GLOBENEWSWIRE
Century Thera Presents New Preclinical Data at the AACR
08 Apr 2024 //
GLOBENEWSWIRE
Century to Present at the H.C. 2nd Annual Cell Therapy Virtual Conference
19 Mar 2024 //
GLOBENEWSWIRE
Century Therapeutics Reports Full Year 2023 Financial Results
14 Mar 2024 //
GLOBENEWSWIRE
Century Therapeutics Announces Six Upcoming Poster Presentations
05 Mar 2024 //
GLOBENEWSWIRE
Century Therapeutics to Present at the 6th Annual Biotechnology Conference
01 Feb 2024 //
GLOBENEWSWIRE
Century Therapeutics Presents Initial Data from CNTY-101 Phase 1 ELiPSE-1 Trial
09 Dec 2023 //
GLOBENEWSWIRE
Century Therapeutics Receives FDA Clearance of IND Application for CNTY-101
06 Dec 2023 //
GLOBENEWSWIRE
Century Therapeutics to Present at Piper Sandler Annual Healthcare Conference
21 Nov 2023 //
GLOBENEWSWIRE
Century Therapeutics Appoints Brent Pfeiffenberger, as Chief Executive Officer
09 Nov 2023 //
GLOBENEWSWIRE
Century Therapeutics and FUJIFILM Cellular Dynamics Announce Licenses
09 Nov 2023 //
GLOBENEWSWIRE
Century Therapeutics Reports Third Quarter 2023 Financial Results
09 Nov 2023 //
GLOBENEWSWIRE
Century to Present Data Supporting Potential for a Strategy for CAR iNK
02 Nov 2023 //
GLOBENEWSWIRE
Century to Present at the Chardan 7th Annual Genetic Medicines Conference
26 Sep 2023 //
GLOBENEWSWIRE
Century Therapeutics Reports Second Quarter 2023 Financial Results
09 Aug 2023 //
GLOBENEWSWIRE
Century Reports First Quarter 2023 Financial Results & Provides Business Updates
11 May 2023 //
GLOBENEWSWIRE
Century to Present at Chardanâ 7th Annual Genetic Medicines & Cell Therapy
17 Apr 2023 //
GLOBENEWSWIRE
Century Therapeutics Announces Leadership Changes
12 Apr 2023 //
GLOBENEWSWIRE
Century Reports Full Year 2022 Financial Results and Provides Business Updates
16 Mar 2023 //
GLOBENEWSWIRE
Century Therapeutics to Present at the AACR Annual Meeting 2023
15 Mar 2023 //
GLOBENEWSWIRE
Century Therapeutics to Present at Upcoming Investor Conferences
21 Feb 2023 //
GLOBENEWSWIRE
Century Announces First Patient Dosed in PI ELiPSE-1 Trial Evaluating CNTY-101
08 Feb 2023 //
GLOBENEWSWIRE
Century Therapeutics to Present at Upcoming Investor Conferences
01 Feb 2023 //
GLOBENEWSWIRE
Century, Elevation to cut assets, staff; Nabriva winds down
06 Jan 2023 //
FIERCE BIOTECH
Century Announces Internal Portfolio Prioritization to Extend Cash Runway
05 Jan 2023 //
GLOBENEWSWIRE
Century Therapeutics to Present at 41st Annual J.P. Morgan Healthcare Conference
04 Jan 2023 //
GLOBENEWSWIRE
Century to Present at the Piper Sandler 34th Annual Healthcare Conference
22 Nov 2022 //
GLOBENEWSWIRE
Century Therapeutics Announces Presentation of Preclinical Data at the SITC 3
11 Nov 2022 //
GLOBENEWSWIRE
Century Therapeutics to Present at the SITC 37th Annual Meeting
05 Oct 2022 //
GLOBENEWSWIRE
Century Therapeutics Announces Appointment of Daphne Quimi
03 Oct 2022 //
GLOBENEWSWIRE
Century Therapeutics to Present at Chardan’s 6th Annual Genetic Medicines
26 Sep 2022 //
GLOBENEWSWIRE
Century Therapeutics to Present at the H.C. Wainwright 24th AnnualGIC
06 Sep 2022 //
GLOBENEWSWIRE
Century Receives Study May Proceed Notification from FDA for CNTY-101
25 Aug 2022 //
GLOBENEWSWIRE
Century Therapeutics Reports Q2 2022 Rusult and Provides Business Updates
11 Aug 2022 //
GLOBENEWSWIRE
Century Therapeutics (NASDAQ:IPSC) Shares Gap Up to $8.88
15 Jul 2022 //
DEFENSE WORLD
Century Therapeutics Announces Its Addition to the Russell Microcap Index
24 Jun 2022 //
GLOBENEWSWIRE
Century Tx to Present at LifeSci Partners 2nd Annual Genetic Medicines Symposium
21 Jun 2022 //
GLOBENEWSWIRE
Century Therapeutics to Host Virtual Research and Development Day
06 Jun 2022 //
GLOBENEWSWIRE
Century Therapeutics Reports First Quarter 2022 Financial Results
16 May 2022 //
GLOBENEWSWIRE
Century Therapeutics to Present at Upcoming Investor Conferences
03 May 2022 //
GLOBENEWSWIRE
Century Therapeutics to Present at the ASGCT 25th Annual Meeting
02 May 2022 //
GLOBENEWSWIRE
Century Tx to Present at Chardan Genetic Medicines and Cell Therapy Summit
18 Apr 2022 //
GLOBENEWSWIRE
Century Tx to Present at 21st Annual Needham Virtual Healthcare Conference
06 Apr 2022 //
GLOBENEWSWIRE
Century Tx to Present at H.C. Wainwright Gene Therapy & Gene Editing Conference
23 Mar 2022 //
GLOBENEWSWIRE
Century Tx Reports Q4 and Year-end 2021 Financial Resultss
17 Mar 2022 //
GLOBENEWSWIRE
Century Therapeutics to Present at the 11th Annual SVB Leerink Conference
09 Feb 2022 //
GLOBENEWSWIRE
Bristol Myers inks $3B in Century, ArsenalBio cell therapy deals
11 Jan 2022 //
FIERCEBIOTECH
Century Therapeutics Added to the NASDAQ Biotechnology Index
17 Dec 2021 //
GLOBENEWSWIRE
Century Therapeutics Announces Presentation of Data at the 63rd
16 Dec 2021 //
GLOBENEWSWIRE
Century Therapeutics to Participate in the Piper Sandler 33rd AVHC
22 Nov 2021 //
GLOBENEWSWIRE
Century to Present at 63rd ASH and Host Virtual Research & Development Update
04 Nov 2021 //
GLOBENEWSWIRE
